Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial

Archives of Dermatology

Volumn 142, Issue 5, 2006, Pages 570-576

  Mentink, Leon F ^a   Mackenzie, Maria W ^a,e   Tóth, Gábor G ^a,f   Laseur, Marianne ^b   Lambert, Frank P G ^b,g   Veeger, Nic J G M ^b   Cianchini, Giuseppe ^c   Pavlović, Miloš D ^d   Jonkman, Marcel F ^a,b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d UNIVERSITY OF DEFENCE   (Serbia)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f MARTINI HOSPITAL   (Netherlands)

^g PRA International USA   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; DEXAMETHASONE; PREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HYPERGLYCEMIA; INFECTION; MALE; MULTICENTER STUDY; MYALGIA; OUTPATIENT; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME;

EID: 33646559224     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.5.570     Document Type: Article

References (25)

1. Bystryn JC, Rudolph JL. Pemphigus. Lancet. 2005;366:61-73.
2. Harman KE, Albert S, Black MM. Guidelines for the management of pemphigus vulgaris. Br J Dermatol. 2003;149:926-937.
3. Pasricha JS, Khaitan BK, Raman RS, Chandra M. Dexamethasone- cyclophosphamide pulse therapy for pemphigus. Int J Dermatol. 1995;34:875-882.
4. Pasricha JS, Thanzama J, Khan UK. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus. Br J Dermatol. 1988;119:73-77.
5. Kaur S, Kanwar AJ. Dexamethasone-cyclophosphamide pulse therapy in pemphigus. Int J Dermatol. 1990;29:371-374.
6. Pasricha JS, Das SS. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris. Int J Dermatol. 1992;31:875-877.
7. Chryssomallis F, Dimitriades A, Chaidemenos GC, Panagiotides D, Karakatsanis G. Steroid-pulse therapy in pemphigus vulgaris long term follow-up. Int J Dermatol. 1995;34:438-442.
8. Pasricha JS, Khaitan BK. Curative treatment for pemphigus. Arch Dermatol. 1996;132:1518-1519.
9. Werth VP. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids. Arch Dermatol. 1996;132:1435-1439.
10. Femiano F, Gombos F, Scully C. Pemphigus vulgaris with oral involvement. J Eur Acad Dermatol Venereol. 2002;16:353-356.
11. Kanwar AJ, Kaur S, Thami GP. Long-term efficacy of dexamethasone- cyclophosphamide pulse therapy in pemphigus. Dermatology. 2002;204:228-231.
12. Mignogna MD, Lo Muzio L, Ruoppo E, Fedele S, Lo Russo L, Bucci E. High-dose intravenous "pulse" methylprednisone in the treatment of severe oropharyngeal pemphigus: a pilot study. J Oral Pathol Med. 2002;31:339-344.
13. Toth GG, van de Meer JB, Jonkman MF. Dexamethasone pulse therapy in pemphigus. J Eur Acad Dermatol Venereol. 2002;16:607-611.
14. Jain R, Kumar B. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy. J Dermatol. 2003;30:713-718.
15. Sacchidanand S, Hiremath NC, Natraj HV, et al. Dexamethasone- cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore. Dermatol Online J. 2003;9:2 http://dermatology. cdlib.org/95/original/pemphigus/sacchidanand.html. Accessed September 5, 2005.
16. Rose E, Wever S, Zillikens D, Linse R, Haustein UF, Brocker EB. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study. J Dtsch Dermatol Ges. 2005;3:200-206.
17. Jain R, Bali H, Sharma VK, Kumar B. Cardiovascular effects of corticosteroid pulse therapy. Int J Dermatol. 2005;44:285-288.
18. Toth GG, Kloosterman C, Uges DR, Jonkman MF. Pharmacokinetics of high-dose oral and intravenous dexamethasone. Ther Drug Monit. 1999;21:532-535.
19. Grando SA, Grando AA, Glukhenky BT, Doguzov V, Nguyen VT, Holubar K. History and clinical significance of mechanical symptoms in blistering dermatoses: a reappraisal. J Am Acad Dermatol. 2003;48:86-92.
20. Sacks O, Shulman M. Steroid dementia. Neurology. 2005;64:707-709.
21. Mahajan VK, Sharma NL, Sharma RC, Garg G. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases. Int J Dermatol. 2005;44:821-827.
22. Talar-Williams C, Hijazi YM, Walther MM, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis. Ann Intern Med. 1996;124:477-484.
23. Burton JL, Harman RR, Peachey RD, Warin RP. Azathioprine plus prednisone in treatment of pemphigoid. BMJ. 1978;2:1190-1191.
24. Lever WF, Schaumburg-Lever G. Treatment of pemphigus vulgaris: results obtained in 84 patients between 1961 and 1982. Arch Dermatol. 1984;120:44-47.
25. Aberer W, Wolf-Schreiner EC, Stingl G, Wolff K. Azathioprine in the treatment of pemphigus vulgaris. J Am Acad Dermatol. 1987;16:527-533.